Figure 6.
Mixed effect regression of individual cellular and plasma biomarkers in subsets of pediatric cGVHD. (A) Pulmonary cGVHD (n = 12). (B) De novo cGVHD (n = 7). (C) Progressive cGVHD (including all cases of overlap syndrome) (n = 18).
Mixed effect regression of individual cellular and plasma biomarkers in subsets of pediatric cGVHD. (A) Pulmonary cGVHD (n = 12). (B) De novo cGVHD (n = 7). (C) Progressive cGVHD (including all cases of overlap syndrome) (n = 18).
